Factors influencing kanamycin resistance in gram-negative enteric neonatal sepsis.
D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy*; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007410:Intestinal Diseases / Q000188:drug therapy*; D007612:Kanamycin / Q000494:pharmacology; D007709:Klebsiella / Q000187:drug effects; D007710:Klebsiella Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy
D005839:Gentamicins; D007612:Kanamycin